225 related articles for article (PubMed ID: 21447260)
1. Bridging the gap between methods research and the needs of policy makers: a review of the research priorities of the National Institute for Health and Clinical Excellence.
Longworth L; Sculpher MJ; Bojke L; Tosh JC
Int J Technol Assess Health Care; 2011 Apr; 27(2):180-7. PubMed ID: 21447260
[TBL] [Abstract][Full Text] [Related]
2. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
Williams I; Bryan S; McIver S
J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
[TBL] [Abstract][Full Text] [Related]
3. A determination of topics for health technology assessment in Thailand: making decision makers involved.
Lertpitakpong C; Chaikledkaew U; Thavorncharoensap M; Tantivess S; Praditsitthikorn N; Youngkong S; Yothasamut J; Udomsuk K; Sinthitichai K; Teerawattananon Y
J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S100-9. PubMed ID: 19253492
[TBL] [Abstract][Full Text] [Related]
4. The role of health technology assessment in the comprehensive evaluation of the impact of immunotherapy on real practice.
Frati F; Ariano R; Cadario G; Ortolani C; Passalacqua G
Eur Ann Allergy Clin Immunol; 2007; 39 Spec No():4-6. PubMed ID: 18924459
[TBL] [Abstract][Full Text] [Related]
5. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
6. National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme research funding and UK burden of disease.
Chinnery F; Bashevoy G; Blatch-Jones A; Douet L; Puddicombe S; Raftery J
Trials; 2018 Feb; 19(1):87. PubMed ID: 29394905
[TBL] [Abstract][Full Text] [Related]
7. Reallocating resources: how should the National Institute for Health and Clinical Excellence guide disinvestment efforts in the National Health Service?
Pearson S; Littlejohns P
J Health Serv Res Policy; 2007 Jul; 12(3):160-5. PubMed ID: 17716419
[TBL] [Abstract][Full Text] [Related]
8. End-of-life care: an interdisciplinary perspective.
Viola D; Leven DC; LePere JC
Am J Hosp Palliat Care; 2009; 26(2):75-8. PubMed ID: 19114604
[TBL] [Abstract][Full Text] [Related]
9. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra.
Claxton K; Sculpher M; McCabe C; Briggs A; Akehurst R; Buxton M; Brazier J; O'Hagan T
Health Econ; 2005 Apr; 14(4):339-47. PubMed ID: 15736142
[TBL] [Abstract][Full Text] [Related]
10. Willingness-to-pay as a measure of benefits. Relevant questions in the context of public decisionmaking about health care programs.
Gafni A
Med Care; 1991 Dec; 29(12):1246-52. PubMed ID: 1745082
[No Abstract] [Full Text] [Related]
11. Prioritized list of health services in the Islamic Republic of Iran.
Larijani B; Ameli O; Alizadeh K; Mirsharifi SR
East Mediterr Health J; 2000; 6(2-3):367-71. PubMed ID: 11556025
[TBL] [Abstract][Full Text] [Related]
12. A national technology assessment institute.
Howell A
Healthplan; 2003; 44(5):40-5. PubMed ID: 14556611
[No Abstract] [Full Text] [Related]
13. Matching taxpayer funding to population health needs: not so simple.
Lauer MS; Gordon D; Olive M
Circ Res; 2015 Apr; 116(8):1301-3. PubMed ID: 25858063
[No Abstract] [Full Text] [Related]
14. Defining products for a new health technology assessment agency in Madrid, Spain: a survey of decision makers.
Andradas E; Blasco JA; Valentín B; López-Pedraza MJ; Gracia FJ
Int J Technol Assess Health Care; 2008; 24(1):60-9. PubMed ID: 18218170
[TBL] [Abstract][Full Text] [Related]
15. [More care for a limited budget; a case for a better use of the efficiency criteria].
Rutten FF; Brouwer WB
Ned Tijdschr Geneeskd; 2002 Nov; 146(47):2254-8. PubMed ID: 12481524
[TBL] [Abstract][Full Text] [Related]
16. Matching taxpayer funding to population health needs.
Hanna M
Circ Res; 2015 Apr; 116(8):1296-300. PubMed ID: 25858062
[TBL] [Abstract][Full Text] [Related]
17. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
18. Developing Health Technology Assessment to address health care system needs.
Velasco Garrido M; Gerhardus A; Røttingen JA; Busse R
Health Policy; 2010 Mar; 94(3):196-202. PubMed ID: 19889471
[TBL] [Abstract][Full Text] [Related]
19. From cost-effectiveness information to decision-making on liquid-based cytology: Mind the gap.
Legood R; Wolstenholme J; Gray A
Health Policy; 2009 Feb; 89(2):193-200. PubMed ID: 18619702
[TBL] [Abstract][Full Text] [Related]
20. Patients' views of explicit rationing: what are the implications for health service decision-making?
Devlin N; Appleby J; Parkin D
J Health Serv Res Policy; 2003 Jul; 8(3):183-6. PubMed ID: 12869346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
